Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Misses Revenue Estimates

Agios Pharmaceuticals (AGIO) came out with a quarterly loss of $1.72 per share versus the Zacks Consensus Estimate of a loss of$ 1.64. This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4.88%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 1.69 per share when it actually produced a loss of $1.64, delivering a surprise of 2.96%.Over the last four quarter ...